CDEK
← All organizations

Cangene

For profitContributed to NME

Also known as: Cangene Corporation | Cangene Corporation a subsidiary of Emergent BioSolutions Inc | Cangene Corporation (doing business as Emergent BioSolutions) | Cangene Plasma Resources, Mid-Florida

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Feb 1, 2006

First marketed drug

Feb 24, 2005

First NDA

Feb 24, 2005

Last known activity

Sep 1, 2015

Acquired by Emergent BioSolutions on Jan 1, 2013

Timeline

1980s

  1. Jan 1, 1984

    Cangene— Founded

2010s

  1. Mar 30, 2012

    varicella zoster immune globulin (human)— NDA Organization

  2. Jan 1, 2013

    Emergent BioSolutions— Acquired By

Drugs by trial phase (9 distinct, 10 trials)

Phase 3 (1 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (3)

Recent trials (13)

Details

Founded
Winnipeg, CA Jan 1, 1984
First NDA
Feb 24, 2005
Last known activity
Sep 1, 2015

Designations held

  • Orphan drug
  • Accelerated approval

Notes

Acquired by Emergent 11 Dec 2013